Capital Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Sell
8,846
-1,441
-14% -$493K 0.2% 121
2026
Q1
$3.62M Sell
10,287
-76
-0.7% -$27.1K 0.26% 90
2025
Q4
$3.39M Buy
10,363
+117
+1% +$37.1K 0.24% 97
2025
Q3
$2.89M Sell
10,246
-362
-3% -$105K 0.23% 107
2025
Q2
$2.96M Buy
10,608
+93
+0.9% +$26.3K 0.24% 97
2025
Q1
$3.28M Buy
10,515
+489
+5% +$144K 0.29% 84
2024
Q4
$2.61M Buy
10,026
+157
+2% +$46.6K 0.25% 87
2024
Q3
$3.18M Sell
9,869
-1,236
-11% -$404K 0.3% 79
2024
Q2
$3.47M Buy
11,105
+418
+4% +$123K 0.36% 68
2024
Q1
$3.04M Sell
10,687
-1,201
-10% -$351K 0.33% 75
2023
Q4
$3.42M Sell
11,888
-146
-1% -$39.8K 0.32% 59
2023
Q3
$3.23M Sell
12,034
-8
-0.1% -$2K 0.32% 59
2023
Q2
$2.67M Buy
12,042
+1,950
+19% +$452K 0.26% 67
2023
Q1
$2.44M Buy
10,092
+75
+0.7% +$18.4K 0.29% 71
2022
Q4
$2.63M Buy
10,017
+1,097
+12% +$294K 0.31% 69
2022
Q3
$2.01M Sell
8,920
-41
-0.5% -$9.94K 0.26% 76
2022
Q2
$2.18M Sell
8,961
-151
-2% -$37K 0.26% 76
2022
Q1
$2.2M Sell
9,112
-26
-0.3% -$5.97K 0.24% 86
2021
Q4
$2.06M Buy
9,138
+489
+6% +$103K 0.24% 90
2021
Q3
$1.84M Buy
8,649
+118
+1% +$27.2K 0.23% 92
2021
Q2
$2.08M Sell
8,531
-51
-0.6% -$12.5K 0.26% 82
2021
Q1
$2.14M Sell
8,582
-178
-2% -$42.5K 0.3% 79
2020
Q4
$2.01M Buy
8,760
+1,345
+18% +$310K 0.3% 77
2020
Q3
$1.89M Buy
7,415
+424
+6% +$105K 0.35% 68
2020
Q2
$1.65M Buy
6,991
+26
+0.4% +$5.93K 0.33% 74
2020
Q1
$1.41M Sell
6,965
-438
-6% -$95.7K 0.34% 65
2019
Q4
$1.78M Sell
7,403
-56
-0.8% -$12.3K 0.48% 44
2019
Q3
$1.44M Buy
7,459
+830
+13% +$159K 0.4% 53
2019
Q2
$1.17M Buy
6,629
+239
+4% +$42.8K 0.35% 55
2019
Q1
$1.21M Sell
6,390
-389
-6% -$74.3K 0.45% 41
2018
Q4
$1.32M Sell
6,779
-74
-1% -$14.4K 0.56% 37
2018
Q3
$1.42M Sell
6,853
-167
-2% -$32.9K 0.67% 37
2018
Q2
$1.3M Sell
7,020
-81
-1% -$14.3K 0.65% 35
2018
Q1
$1.21M Buy
7,101
+62
+0.9% +$11.4K 0.68% 32
2017
Q4
$1.22M Buy
7,039
+85
+1% +$15K 0.72% 30
2017
Q3
$1.3M Buy
6,954
+30
+0.4% +$5.32K 0.8% 30
2017
Q2
$1.19M Sell
6,924
-292
-4% -$47.5K 0.79% 31
2017
Q1
$1.18M Buy
7,216
+10
+0.1% +$1.66K 0.87% 26
2016
Q4
$1.05M Buy
+7,206
New +$1.08M 0.91% 25

Other funds holding AMGN

Capital Investment Advisory Services's AMGN Position: Q2 2026 in Review

Capital Investment Advisory Services reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $493K and leaving 8,846 shares worth $3.2M. The position accounts for 0.2% of the portfolio, ranked #121.

Capital Investment Advisory Services first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.62M in Q1 2026. 1,324 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Investment Advisory Services held 8,846 shares of Amgen worth $3.2M as of Q2 2026.
  • Capital Investment Advisory Services sold 1,441 Amgen shares in Q2 2026, an estimated $493K.
  • Amgen made up 0.2% of Capital Investment Advisory Services's portfolio in Q2 2026, its #121 holding.
  • Capital Investment Advisory Services first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
  • Capital Investment Advisory Services's Amgen position peaked at $3.62M in Q1 2026.
  • 1,324 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.